- Inicio
- Listar por autor
Listar por autor "López, G."
Mostrando ítems 1-3 de 3
-
Differences in lifetime patterns of psychostimulants and their impact on the proportion of patients with first-episode psychosis attributable to psychostimulants use across europe
Duran-Cutilla, Manuel; Toscano, Elisa Rodriguez; Fraguas, David; López, G.; Rapado-Castro, Marta; Roldán, Laura; Sánchez-Gutiérrez, Teresa; Calvo, Ana; Martínez-Caneja, Covadonga; Arango, Celso (Schizophrenia Bulletin, 18/05/2020)Meeting Abstract de la conferencia "Congress of the Schizophrenia-International-Research-Society (SRIS)", Italia, 2020 -
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence
Lamanna-Rama, N.; MacDowell, K.S.; López, G.; Leza, J.C.; Desco, M.; Ambrosio, E.; Soto-Montenegro, M.L. (European Neuropsychopharmacology, 2023)This study evaluates the long-term effects of a six and 14-week morphine withdrawal in rats pretreated with a cannabinoid agonist (CP-55,940, CP) during periadolescence. Wistar rats (33 males; 32 females) were treated with ... -
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Sanchez-Gutierrez, Teresa; Rodriguez-Toscano, E.; Ferraro, Laura; Parellada, Mara; Calvo, Ana; Roldan, Laura; López, G.; Rapado-Castro, Marta; La Barbera, Daniele; La Cascia, Caterina; Tripoli, Giada; Di Forti, Marta; Murray, Robin M.; Quattrone, Diego; Morgan, Craig; Van Os, Jim; Garcia-Portilla, P.; Al-Halabi, S.; Bobes, Julio; de Haan, Lieuwe; Bernardo, Miguel; Santos, Jose Luis; Sanjuán, Julio; Arrojo, Manuel; Ferchiou, A.; Szöke, Andrei; Rutten, Bart P.; Stilo, S.; D'Andrea, G.; Tarricone, Ilaria; Diaz-Caneja, C. M.; Arango, Celso (Psychological Medicine, 2023)BackgroundTobacco is a highly prevalent substance of abuse in patients with psychosis. Previous studies have reported an association between tobacco use and schizophrenia. The aim of this study was to analyze the relationship ...